111 INC (YI) Stock Price, Quote, News and Overview
NASDAQ:YI - Nasdaq - US68247Q1022 - ADR - Currency: USD
YI Quote, Performance and Key Statistics
111 INC
NASDAQ:YI (1/24/2025, 8:16:50 PM)
5.28
+0.61 (+12.94%)
The current stock price of YI is 5.28 USD. In the past month the price decreased by -28.66%. In the past year, price decreased by -64.56%.
YI Latest News, Press Releases and Analysis
Top movers in Friday's session
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Top movers in Friday's session
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Friday's session: gap up and gap down stocks
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
111, Inc. Announces ADS Ratio Change
/PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of...
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
/PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of...
YI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WBA | WALGREENS BOOTS ALLIANCE INC | 4.35 | 10.25B | ||
| GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.37B | ||
| CJJD | CHINA JO-JO DRUGSTORES HOLDI | N/A | 11.70M | ||
| MGRX | MANGOCEUTICALS INC | N/A | 9.21M |
Related stock screener links
About YI
Company Profile
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,520 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
Company Info
111 INC
3-4/F, No.295 Zuchongzhi Road, Pudong New Area
Shanghai SHANGHAI 201203 CN
CEO: Junling Liu
Employees: 1520
Company Website: http://gangling.111.com.cn/
Investor Relations: http://ir.111.com.cn/
Phone: 862120536666
YI FAQ
What is the stock price of YI?
The current stock price of YI is 5.28 USD.
What is the symbol for 111 INC stock?
The exchange symbol of 111 INC is YI and it is listed on the Nasdaq exchange.
On which exchange is YI stock listed?
YI stock is listed on the Nasdaq exchange.
Is YI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for YI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of YI.
Does YI stock pay dividends?
YI does not pay a dividend.
What is the Price/Earnings (PE) ratio of YI?
YI does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).
What is the Short Interest ratio of YI stock?
The outstanding short interest for YI is 0.29% of its float.
YI Technical Analysis
YI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to YI. YI has a bad profitability rating. Also its financial health evaluation is rather negative.
YI Financial Highlights
Over the last trailing twelve months YI reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS decreased by 15.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.43% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
YI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 87% to YI. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 142.3% and a revenue growth 18.38% for YI